Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2015 | -21.37 Million USD | -64.34% |
| 2014 | -13 Million USD | -63.7% |
| 2013 | -7.94 Million USD | -3.77% |
| 2012 | -7.65 Million USD | -34.77% |
| 2011 | -5.68 Million USD | -16.41% |
| 2010 | -4.88 Million USD | 48.11% |
| 2009 | -9.4 Million USD | 4.6% |
| 2008 | -9.86 Million USD | -79.35% |
| 2007 | -5.49 Million USD | -236.32% |
| 2006 | -1.63 Million USD | -185.0% |
| 2005 | 1.92 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2015 FY | -21.37 Million USD | -64.34% |
| 2015 Q1 | -3.64 Million USD | -18.68% |
| 2014 Q2 | -3.1 Million USD | 10.65% |
| 2014 Q3 | -3.35 Million USD | -7.95% |
| 2014 Q4 | -3.06 Million USD | 8.55% |
| 2014 Q1 | -3.47 Million USD | -10.35% |
| 2014 FY | -13 Million USD | -63.7% |
| 2013 Q1 | -784.15 Thousand USD | -66.96% |
| 2013 Q4 | -3.15 Million USD | -15.14% |
| 2013 Q2 | -1.27 Million USD | -62.31% |
| 2013 Q3 | -2.73 Million USD | -115.07% |
| 2013 FY | -7.94 Million USD | -3.77% |
| 2012 FY | -7.65 Million USD | -34.77% |
| 2012 Q4 | -469.66 Thousand USD | 66.33% |
| 2012 Q3 | -1.39 Million USD | 48.46% |
| 2012 Q2 | -2.7 Million USD | 12.72% |
| 2012 Q1 | -3.1 Million USD | 21.15% |
| 2011 Q2 | -84.56 Thousand USD | 66.73% |
| 2011 Q4 | -3.93 Million USD | -178.99% |
| 2011 FY | -5.68 Million USD | -16.41% |
| 2011 Q1 | -254.16 Thousand USD | 80.6% |
| 2011 Q3 | -1.4 Million USD | -1567.14% |
| 2010 Q4 | -1.3 Million USD | -23.65% |
| 2010 Q2 | -424.01 Thousand USD | 79.69% |
| 2010 Q1 | -2.08 Million USD | -17.63% |
| 2010 FY | -4.88 Million USD | 48.11% |
| 2010 Q3 | -1.05 Million USD | -149.85% |
| 2009 FY | -9.4 Million USD | 4.6% |
| 2009 Q1 | -3.27 Million USD | 5.19% |
| 2009 Q4 | -1.77 Million USD | 9.94% |
| 2009 Q2 | -2.38 Million USD | 27.16% |
| 2009 Q3 | -1.97 Million USD | 17.4% |
| 2008 Q3 | -1.09 Million USD | 50.97% |
| 2008 Q1 | -1.89 Million USD | -74.88% |
| 2008 FY | -9.86 Million USD | -79.35% |
| 2008 Q4 | -3.45 Million USD | -214.21% |
| 2008 Q2 | -2.24 Million USD | -18.48% |
| 2007 FY | -5.49 Million USD | -236.32% |
| 2007 Q4 | -1.08 Million USD | 1.56% |
| 2007 Q3 | -1.09 Million USD | 56.53% |
| 2007 Q2 | -2.52 Million USD | -221.56% |
| 2007 Q1 | -786.56 Thousand USD | -7.23% |
| 2006 Q4 | -733.53 Thousand USD | -98.51% |
| 2006 FY | -1.63 Million USD | -185.0% |
| 2006 Q3 | -369.51 Thousand USD | -128.87% |
| 2006 Q1 | 1.26 Million USD | 0.0% |
| 2006 Q2 | 1.27 Million USD | 0.87% |
| 2005 FY | 1.92 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -1621.176% |
| Arrayit Corporation | -3.62 Million USD | -490.114% |
| Atlantic International Corp. | -5.73 Million USD | -272.908% |
| Biocept, Inc. | -31.98 Million USD | 33.161% |
| Bioqual, Inc. | -19.63 Thousand USD | -108755.281% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -2668.532% |
| DermTech, Inc. | -103.73 Million USD | 79.393% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.86% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | -2.628% |
| iMD Companies, Inc. | -175.44 Thousand USD | -12084.376% |
| IDenta Corp. | -1499.00 USD | -1425984.056% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 862.375% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 55352.003% |
| InVitro International | -25.33 Thousand USD | -84264.024% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -200.154% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -36685.862% |
| Medical Imaging Corp. | -819.48 Thousand USD | -2508.605% |
| NovelStem International Corp. | -3.52 Million USD | -506.302% |
| Optigenex Inc. | 1.39 Million USD | 1636.99% |
| PharmChem, Inc. | 973.14 Thousand USD | 2296.688% |
| Proteome Sciences plc | -1.62 Million USD | -1218.754% |
| Rennova Health, Inc. | -1.4 Million USD | -1416.601% |
| RushNet, Inc. | -684.7 Thousand USD | -3022.074% |
| ScreenPro Security Inc. | -2.59 Million USD | -724.594% |
| Stella Diagnostics Inc. | -11.42 Million USD | -87.075% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -175.948% |
| Todos Medical Ltd. | -9.74 Million USD | -119.296% |